CERo Therapeutics Holdings, Inc.

NASDAQ (USD): CERo Therapeutics Holdings, Inc. (CERO)

Last Price

1.98

Today's Change

-0.02 (1.00%)

Day's Change

1.96 - 2.09

Trading Volume

145,985

Overview

Market Cap

5 Million

Shares Outstanding

2 Million

Avg Volume

1,193,277

Avg Price (50 Days)

8.38

Avg Price (200 Days)

33.59

PE Ratio

-0.02

EPS

-118.56

Earnings Announcement

18-Feb-2025

Previous Close

2.00

Open

2.01

Day's Range

1.96 - 2.0941

Year Range

1.76 - 1280.0

Trading Volume

146,608

Price Change Highlight

1 Day Change

-1.00%

5 Day Change

-5.71%

1 Month Change

-65.98%

3 Month Change

-73.64%

6 Month Change

-87.37%

Ytd Change

-67.54%

1 Year Change

-99.80%

3 Year Change

-99.80%

5 Year Change

-99.80%

10 Year Change

-99.80%

Max Change

-99.80%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment